Nektar Therapeutics is headquartered in San Francisco and its pipeline includes a modified CSF protein.
1 report, 0 independent
Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nektar Therapeutics is headquartered in San Francisco and its pipeline includes a modified CSF protein.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CSF
Nothing else this week.
-
Nektar Therapeutics
American healthcare company
Nothing else this week.
-
San Francisco
consolidated city and county in California, United States
Related events
- Multiple financial firms, including KBC Group NV, WINTON GROUP Ltd, and Deutsche Bank, increased their stakes in Nektar Therapeutics on September 12, 2026.
- Nathan Miller is associated with an investigation involving Nektar Therapeutics.
- Nektar Therapeutics is seeking FDA review for its late-stage drug trials.
Coverage
Newest first; wire copies grouped- Unknown outlet